Subsidy strategy of pharmaceutical e-commerce platform based on two-sided market theory.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31671133.
- Also identified by DOI 10.1371/journal.pone.0224369 and PMC identifier 6822757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With the development of economic globalization and information technology, enterprises pay more attention to the sustainable development of their e-commerce. Under this trend, we study the subsidy strategy commonly used by pharmaceutical e-commerce platforms in two-sided market. Based on the two-sided market theory, we set up the two-sided user's utility function and formulate the subsidy strategy as the decision of platform profit optimization. We show that the platform chooses to subsidize consumers only if the net income from consumer is lower than the total revenue of drug retailers and platforms in each transaction; the maximum profit for platform increases with the intensity of the network externality. This study provides theoretical support and decision-making suggestions for the pharmaceutical e-commerce platforms to capture the market share, obtain higher profits and ultimately achieve the sustainable development goal.
Medical subject headings
- Commerce
- Economic Competition
- Economics, Pharmaceutical